Specifically, the high PGLS expression predicts poor OS, PPS in male gastric cancer patients, in patients with lymph node metastasis and in patients with Her‐2 (‐). The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.